| - GRCh37:
- Chr11:125765587
- GRCh38:
- Chr11:125895692
| HYLS1, PUS3 | R159H | Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome, not provided | Uncertain significance (Jan 27, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:125765566
- Chr11:125765167
- GRCh38:
- Chr11:125895671
- Chr11:125895272
| HYLS1, PUS3, HYLS1, PUS3 | R166Q, I299S, I91S | Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome | Uncertain significance (Nov 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:125765968
- GRCh38:
- Chr11:125896073
| HYLS1, PUS3 | Y71C | Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome, not provided | Conflicting interpretations of pathogenicity (Oct 5, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:125766162-125766163
- GRCh38:
- Chr11:125896267-125896268
| HYLS1, PUS3 | T6fs | Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome | Likely pathogenic (Jun 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr11:125766173
- GRCh38:
- Chr11:125896278
| HYLS1, PUS3 | Y3D | Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome, not provided | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:125766044
- GRCh38:
- Chr11:125896149
| HYLS1, PUS3 | A46S | Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome, not provided | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:125763746
- GRCh38:
- Chr11:125893851
| HYLS1, PUS3 | E252D, E460D | Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome, not provided | Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:125765813-125765814
- GRCh38:
- Chr11:125895918-125895919
| HYLS1, PUS3 | A123fs | Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome | Pathogenic/Likely pathogenic (Sep 2, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:125764044
- GRCh38:
- Chr11:125894149
| PUS3, HYLS1 | M153K, M361K | Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome | Uncertain significance (Jan 3, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr11:125764078
- GRCh38:
- Chr11:125894183
| HYLS1, PUS3 | Q350*, Q142* | Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome | Likely pathogenic (Mar 25, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr11:125766179
- GRCh38:
- Chr11:125896284
| HYLS1, PUS3 | M1V | Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome, not provided | Pathogenic/Likely pathogenic (Sep 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:125765566
- GRCh38:
- Chr11:125895671
| HYLS1, PUS3 | R166Q | Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome, not provided | Uncertain significance (Feb 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr11:125765485
- GRCh38:
- Chr11:125895590
| HYLS1, PUS3 | R193Q | not provided | Uncertain significance (May 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr11:125763944-125763945
- GRCh38:
- Chr11:125894049-125894050
| HYLS1, PUS3 | S394fs, S186fs | Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome | Likely pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr11:125763823
- GRCh38:
- Chr11:125893928
| HYLS1, PUS3 | R435*, R227* | Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome | Pathogenic (Jun 30, 2021) | criteria provided, single submitter |